Shell Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,402
Closed -$138K 1389
2022
Q3
$138K Sell
10,402
-2,713
-21% -$46.8K 0.01% 1130
2022
Q2
$251K Buy
13,115
+35
+0.3% +$663 0.01% 1049
2022
Q1
$261K Sell
13,080
-1,919
-13% -$38.8K 0.01% 1091
2021
Q4
$306K Buy
14,999
+53
+0.4% +$1.13K 0.01% 1102
2021
Q3
$322K Sell
14,946
-640
-4% -$15.4K 0.01% 1057
2021
Q2
$450K Buy
15,586
+840
+6% +$22.7K 0.01% 961
2021
Q1
$360K Hold
14,746
0.01% 982
2020
Q4
$286K Hold
14,746
0.01% 1023
2020
Q3
$257K Hold
14,746
0.01% 968
2020
Q2
$387K Sell
14,746
-144
-1% -$3.58K 0.01% 777
2020
Q1
$360K Sell
14,890
-228
-2% -$5.57K 0.01% 801
2019
Q4
$375K Sell
15,118
-407
-3% -$9.45K 0.01% 986
2019
Q3
$331K Sell
15,525
-133
-0.8% -$3.64K 0.01% 1046
2019
Q2
$497K Sell
15,658
-358
-2% -$11.2K 0.01% 921
2019
Q1
$529K Hold
16,016
0.01% 888
2018
Q4
$515K Sell
16,016
-1,400
-8% -$52.8K 0.01% 832
2018
Q3
$747K Buy
+17,416
New +$823K 0.01% 823

Other funds holding PAHC

Shell Asset Management's PAHC Position: Q4 2022 in Review

Shell Asset Management sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 10,402 shares — an estimated $138K sold.

Shell Asset Management first reported a position in PAHC in Q3 2018 and held it in 17 quarters. The position peaked at $747K in Q3 2018. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Shell Asset Management reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Shell Asset Management sold 10,402 Phibro Animal Health shares in Q4 2022, an estimated $138K.
  • Shell Asset Management first reported a position in Phibro Animal Health in Q3 2018 and held it in 17 quarters.
  • Shell Asset Management's Phibro Animal Health position peaked at $747K in Q3 2018.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Shell Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.